Skip to main content

Table 6 Multivariate Cox regression analyses for the factors associated with overall survival

From: Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

  OS
Variables HR 95% CI p-value
Initial clinical stage 3.597 1.037–12.480 0.044
ER 3.329 0.296–37.454 0.330
bcl-2 3.027 0.557–16.437 0.200
Triple negative 1.847 0.492–6.935 0.364